BRANFORD, Conn., Sept. 20 /PRNewswire-FirstCall/ -- Neurogen Corporation (Nasdaq: NRGN - News), a drug discovery and development company, announced today that William H. Koster, President and CEO, will present a Company overview and pipeline update at the UBS Global Life Sciences Conference on Wednesday, September 27, 2006 at 3:30 p.m. ET.
